MedTrace Logo

Alzheimer's Caregiver Coping: Mental and Physical Health

NCT02317523 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 151

Last updated 2019-09-26

No results posted yet for this study

Summary

This study evaluates the effectiveness of Behavioral Activation (BA) therapy vs Support and Information for reducing risk for emotional and cardiovascular diseases in Alzheimer's caregivers. Half of participants will receive BA and the other half will receive support and information.

Conditions

Interventions

BEHAVIORAL

Behavioral Activation

Six face-to-face sessions (60 minutes each) of Behavioral Activation (BA) therapy

BEHAVIORAL

Information and Support

Six face-to-face sessions (60 minutes each) of Supportive Therapy

Sponsors & Collaborators

Principal Investigators

  • Brent T Mausbach, PhD · University of California, San Diego

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
55 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-09-30
Primary Completion
2019-06-30
Completion
2019-06-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02317523 on ClinicalTrials.gov